TLX - Telix Pharmaceuticals Ltd

QQQ $ 605.40 $ -0.79 (-0.13 %)

DIA $ 469.06 $ -1.78 (-0.38 %)

SPY $ 668.08 $ -1.65 (-0.25 %)

TLT $ 89.23 $ 0.15 (0.17 %)

GLD $ 373.50 $ -0.41 (-0.11 %)

Previous Close

$ 9.34

Open

$ 9.37

Bid

$ 9.20 x 26

Ask

$ 9.23 x 92

Day's Range

$ 9.25 - $ 9.40

52 Week Range

$ 8.93 - $ 30.36

Volume

127,516

Average Volume

Market Cap

3.13B

Beta (5Y Monthly)

$ 1.95

PE Ratio (TTM)

$ 101.26

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Telix's TLX250-CDx Included In Global Nucl...
10/23/2025 11:11:20

Telix Pharmaceuticals Doses First Patient ...
10/22/2025 20:03:00

telix-pharmaceuticals-enters-q4-on-strong-footing-with-stabilized-pricing-pressures-upgraded-annual-sales-guidance

Telix Pharmaceuticals Enters Q4 On Strong ...
10/14/2025 18:11:10

Telix Pharmaceuticals posts 53% Q3 revenue growth to $206 million, lifts FY25 guidance to up to $820 million amid strong PSMA i...

Telix Pharmaceuticals Sees Q3 Sales $206.000M
10/14/2025 07:21:54

Telix Pharmaceuticals (NASDAQ:TLX) sees Q3 sales of $206.000 million.

Telix Pharmaceuticals Raises FY2025 Sales ...
10/14/2025 07:21:39

Telix Pharmaceuticals (NASDAQ:TLX) raises FY2025 sales outlook from $770.000 million-$800.000 million to $800.000 million-$820....

Telix Reports Q3 Revenue Of $206M Up 53% Y...
10/14/2025 06:31:27

CORRECTION: UBS Analyst David Dai Maintain...
09/24/2025 13:41:08

US Centers For Medicare & Medicaid Service...
09/23/2025 14:17:49

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix") today announces that the United States (U.S.) Centers for...

Citigroup Initiates Coverage On Telix Phar...
09/18/2025 15:21:06

Citigroup analyst Laura Sutcliffe initiates coverage on Telix Pharmaceuticals (NASDAQ:TLX) with a Buy rating and announces P...

HC Wainwright & Co. Maintains Buy on Telix...
09/10/2025 14:29:01

HC Wainwright & Co. analyst Robert Burns maintains Telix Pharmaceuticals (NASDAQ:TLX) with a Buy and lowers the price ta...

Reported Earlier, Telix Initiates Phase 3 ...
09/10/2025 07:38:28

JP Morgan Downgrades Telix Pharmaceuticals...
08/28/2025 20:09:03

JP Morgan downgrades Telix Pharmaceuticals (NASDAQ:TLX) from Overweight to Neutral.

telix-gets-second-fda-rejection-for-kidney-cancer-drug

Telix Gets Second FDA Rejection For Kidney...
08/28/2025 17:08:18

FDA sent a second CRL to Telix, delaying its kidney cancer PET drug. Analysts weigh pricing pressure, and growth opportunities.

Wedbush Reiterates Outperform on Telix Pha...
08/28/2025 13:12:29

Wedbush analyst David Nierengarten reiterates Telix Pharmaceuticals (NASDAQ:TLX) with a Outperform and maintains $22 price t...

cooper-companies-posts-downbeat-sales-joins-netapp-urban-outfitters-nvidia-and-other-big-stocks-moving-lower-in-thursday-pre-market-session

Cooper Companies Posts Downbeat Sales, Joi...
08/28/2025 12:20:40

12 Health Care Stocks Moving In Thursday's...
08/28/2025 12:08:20

why-snowflake-shares-are-trading-higher-by-14-here-are-20-stocks-moving-premarket

Why Snowflake Shares Are Trading Higher By...
08/28/2025 09:48:22

12 Health Care Stocks Moving In Wednesday'...
07/23/2025 17:06:04

texas-instruments-sap-enphase-energy-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Texas Instruments, SAP, Enphase Energy And...
07/23/2025 12:35:44

12 Health Care Stocks Moving In Wednesday'...
07/23/2025 12:08:15